Mironid

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Mironid operates in biotechnology, health diagnostics, life science, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2014.

Mironid is positioned in biotechnology, health diagnostics, life science, therapeutics, a segment that rewards a clear, focused offering.

The business is associated with Europe, Middle East, and Africa (EMEA).

The company is listed at the Series_A stage of development.

The company reports a headcount in the c_00011_00050 range.

Public records show total funding of about $35M.

Website: www.mironid.com